Idexx Laboratories (IDXX) Operating Leases (2019 - 2026)

Idexx Laboratories has reported Operating Leases for 8 years, with the latest figure at $127.2 million in Q2 2026.

• On a quarterly basis, Operating Leases fell 4.68% year-over-year to $127.2 million in Q2 2026; TTM through Jun 2026 was $127.2 million, a 4.68% decrease from a year earlier, with the FY2025 full-year figure at $101.2 million, up 3.39% from the prior year.
• Operating Leases was $127.2 million for Q2 2026 at Idexx Laboratories, up from $125.6 million in the prior quarter.
• The five-year high for Operating Leases was $133.5 million in Q2 2025, with the low at $97.8 million in Q4 2024.
• Average Operating Leases over 5 years is $116.9 million, with a median of $118.5 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2026: Operating Leases gained 15.86% in 2022, then slipped 4.68% in 2026.
• Over 5 years, Operating Leases stood at $101.2 million in 2022, then decreased by 1.55% to $99.7 million in 2023, then fell by 1.84% to $97.8 million in 2024, then grew by 3.39% to $101.2 million in 2025, then grew by 25.77% to $127.2 million in 2026.
• The last three Operating Leases figures came in at $127.2 million (Q2 2026), $125.6 million (Q1 2026), and $101.2 million (Q4 2025), per Business Quant data.